Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Quick titration of pergolide in cotreatment with domperidone is safe and effective.

Jansen PA, Herings RM, Samson MM, De Vreede PL, Schuurmans-Daemen LM, Hovestadt A, Verhaar HJ, Van Laar T.

Clin Neuropharmacol. 2001 May-Jun;24(3):177-80.

PMID:
11391131
2.

High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.

Parkinsonism Relat Disord. 2005 Sep;11(6):393-8.

PMID:
15993640
3.

High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.

Arnold G, Gasser T, Storch A, Lipp A, Kupsch A, Hundemer HP, Schwarz J.

Arch Gerontol Geriatr. 2005 Nov-Dec;41(3):239-53. Epub 2005 Jul 18.

PMID:
16029905
4.
5.

Mesulergine and pergolide in previously untreated Parkinson's disease.

Wright A, Lees AJ, Stern GM.

J Neurol Neurosurg Psychiatry. 1987 Apr;50(4):482-4.

6.

A six-month study of pergolide and levodopa in de novo Parkinson's disease patients.

Kulisevsky J, López-Villegas D, García-Sánchez C, Barbanoj M, Gironell A, Pascual-Sedano B.

Clin Neuropharmacol. 1998 Nov-Dec;21(6):358-62.

PMID:
9844794
7.

Treatment of restless leg syndrome with pergolide--an open clinical trial.

Winkelmann J, Wetter TC, Stiasny K, Oertel WH, Trenkwalder C.

Mov Disord. 1998 May;13(3):566-9.

PMID:
9613756
8.

An open label trial of pergolide in Thai patients with Parkinson's disease.

Poungvarin N, Prayoonwiwat N, Devahasatin V, Viriyavejakul A.

J Med Assoc Thai. 1996 Apr;79(4):205-9.

PMID:
8708504
9.
10.

Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study.

Suwantamee J, Nidhinandana S, Srisuwananukorn S, Laptikultham S, Pisarnpong A, Chankrachang S, Bundhukul A.

J Med Assoc Thai. 2004 Nov;87(11):1293-300.

PMID:
15825702
11.

Pergolide in the treatment of patients with early and advanced Parkinson's disease.

Bonuccelli U, Colzi A, Del Dotto P.

Clin Neuropharmacol. 2002 Jan-Feb;25(1):1-10. Review.

PMID:
11852289
12.

Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.

Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW.

Mov Disord. 1997 Nov;12(6):952-7.

PMID:
9399220
13.

Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow?

Goetz CG, Blasucci L, Stebbins GT.

Neurology. 1999 Apr 12;52(6):1227-9.

PMID:
10214748
14.

[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].

de Yébenes JG, García-Ruiz PJ, Sánchez-Pernaute R.

Rev Neurol. 1997 Sep;25(145):1343-5. Spanish.

PMID:
9377286
15.

Pergolide and Parkinson's disease: new preparation. No clear benefit.

[No authors listed]

Prescrire Int. 2000 Dec;9(50):177-9.

PMID:
11475497
16.

Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease.

Thalamas C, Rajman I, Kulisevsky J, Lledó A, Mackie AE, Blin O, Gillespie TA, Seger M, Rascol O.

Clin Neuropharmacol. 2005 May-Jun;28(3):120-5. Erratum in: Clin Neuropharmacol. 2005 Sep-Oct;28(5):254.

PMID:
15965310
17.

[Optimum dosage of pergolide in patients with Parkinson's disease].

Neshige R.

Rinsho Shinkeigaku. 2005 Apr;45(4):328-30. Japanese.

PMID:
15912805
18.

[Pergolide: a useful agonist for the treatment of Parkinson disease].

Bonnet AM, Houeto JL.

Rev Neurol (Paris). 2002 Jul;158(6-7):744-5. French.

PMID:
12486908
19.

Trial of subtherapeutic pergolide in de novo Parkinson's disease.

Grosset K, Grosset D, Lees A; Parkinson's Disease Research Group of the United Kingdom.

Mov Disord. 2005 Mar;20(3):363-6.

PMID:
15580607
20.

Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide.

Jiménez-Jiménez FJ, López-Alvarez J, Sánchez-Chapado M, Montero E, Miquel J, Sierra A, Gutiérrez F.

Clin Neuropharmacol. 1995 Jun;18(3):277-9.

PMID:
8635187

Supplemental Content

Support Center